Get started
Author

Hassan Jaafar

Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: Short report from a single centre
2014 · H. Alizadeh, H. Jaafar, et al. · Leukemia Research · 33
The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force.
2020 · Humaid Al-Shamsi, Humaa Darr, et al. · PubMed · 32
Supportive care needs of multicultural patients with cancer in the United Arab Emirates
2018 · Satish Chandrasekhar Nair, Hassan Jaafar, et al. · ecancermedicalscience · 32
PDF
Breast Cancer in the United Arab Emirates
2023 · Humaid O. Al-Shamsi, Nadia Abdelwahed, et al. · JCO Global Oncology · 30
PDF
Bilateral breast involvement in acute myelogenous leukemia
2000 · N. J. Khoury, F. M. Hanna Al-Kass, et al. · European Radiology · 27
Breast Cancer in the Arabian Gulf Countries
2023 · Humaid O. Al-Shamsi, Nadia Abdelwahed, et al. · Cancers · 22
PDF
Impact of Oncotype DX testing on adjuvant treatment decisions in patients with early breast cancer: A single-center study in the United Arab Emirates
2014 · Hassan Jaafar, Mohamed Al Bashir, et al. · Asia-Pacific Journal of Clinical Oncology · 20
A multicenter prospective phase II trial of neoadjuvant epirubicin, cyclophosphamide, and 5-fluorouracil (FEC100) followed by cisplatin–docetaxel with or without trastuzumab in locally advanced breast cancer
2015 · Taher AL-Tweigeri, Adher AlSayed, et al. · Cancer Chemotherapy and Pharmacology · 18
Interferon alpha is an effective therapy for congenital dyserythropoietic anaemia type I
2000 · Ali Shamseddine, Ali Taher, et al. · European Journal Of Haematology · 18
Serum Flt3 Ligand Variation as a Predictive Indicator of Hematopoietic Stem Cell Mobilization
2002 · Joud H. Haidar, Ali Bazarbachi, et al. · Stem Cells and Development · 15
Real-World Data on the Prevalence of Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer in the Middle East and North Africa
2021 · Abdul Rahman Jazieh, Rabab Gaafar, et al. · JCO Global Oncology · 14
The Study of Druggable Targets in Nonsquamous Non-Small-Cell Lung Cancer in the Middle East and North Africa
2019 · Abdul Rahman Jazieh, Adda Bounedjar, et al. · Journal of Immunotherapy and Precision Oncology · 11
Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports
2015 · Hussain Alizadeh, Hassan Jaafar, et al. · Annals of Saudi Medicine · 11
Epidermal growth factor receptor (EGFR) positive non-small-cell lung carcinoma (NSCLC) patients in the Gulf region: current status, challenges, and call for action
2020 · Hassan Jaafar, Ahmed Mohieldin, et al. · Journal of Cancer Prevention & Current Research · 6
PDF
The Role of Direct Oral Anticoagulants in the Treatment of Cancer-Associated Venous Thromboembolism: Review by Middle East and North African Experts
2024 · Shouki Bazarbashi, Heba El Zawahry, et al. · Journal of Blood Medicine · 5
The first Middle East and North Africa expert consensus recommendations for the management of advanced colorectal cancer
2022 · Hampig R Kourie, Fahad Ibnshamsah, et al. · Future Oncology · 5
Patterns of diagnostic procedures for lung cancer pathology in the Middle East and North Africa
2019 · Abdul Rahman Jazieh, Adda Bounedjar, et al. · Journal of Thoracic Disease · 4
PDF
Metastatic castration resistant prostate cancer: Current strategies of management in the Middle East
2013 · Shouki Bazarbashi, Marwan Bachour, et al. · Critical Reviews in Oncology/Hematology · 4
Epidermal growth factor receptor mutation (EGFRMUT) in non-small cell lung cancer (NSCLC) in the Middle East.
2013 · Abdul Rahman Jazieh, Hassan Nadim Jaafar, et al. · Journal of Clinical Oncology · 4
Frontline Management of Advanced Epithelial Ovarian Cancer: A Comprehensive Statement by the Africa Middle East Cancer Inter-group [AMCI]
2022 · Mudieddine Seoud, Amel Ladjeroud, et al. · Current Women s Health Reviews · 2
Post-CDK4/6 Inhibitor Therapeutic Approaches in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Current Evidence and Emerging Strategies—A Narrative Review
2026 · Humaid O. Al-Shamsi, Nadia Abdelwahed, et al. · Diagnostics · 1
Monitoring and management of adverse effects associated with trastuzumab deruxtecan: a UAE-specific consensus
2025 · Emad Dawoud, Fathi Azribi, et al. · Frontiers in Oncology · 1
PDF
[Life-threatening gastrointestinal bleeding related to the treatment of strongyloidiasis hyperinfection in an immunocompromised patient].
2004 · Hassan Jaafar, Jorgen Kristensen, et al. · PubMed · 1
2663eP OPERA: A prospective observational study to describe the pattern and effectiveness of the utilization of different treatment options for metastatic renal cell carcinoma
2025 · M. Ghosn, N. Damaj, et al. · Annals of Oncology
Unmet needs in cancer patients: Creating recommendations to overcome geographical disparities in economic growth
2023 · Wafaa Ayesh, Azza Adel Ibrahim Hassan, et al. · Clinical Nutrition ESPEN
PDF
Works count: 29
Citation count: 316
H-index: 11
I10-index: 13
Year
Topic
Type